HRP20020762B1 - N-(heterocyklyl)benzene or pyridine sulphonamides as antithrombotic agens and anticoagulants - Google Patents

N-(heterocyklyl)benzene or pyridine sulphonamides as antithrombotic agens and anticoagulants

Info

Publication number
HRP20020762B1
HRP20020762B1 HR20020762A HRP20020762A HRP20020762B1 HR P20020762 B1 HRP20020762 B1 HR P20020762B1 HR 20020762 A HR20020762 A HR 20020762A HR P20020762 A HRP20020762 A HR P20020762A HR P20020762 B1 HRP20020762 B1 HR P20020762B1
Authority
HR
Croatia
Prior art keywords
heterocyklyl
agens
sulphonamides
antithrombotic
anticoagulants
Prior art date
Application number
HR20020762A
Other languages
English (en)
Inventor
Altenburger Jean-Michel
Cremer Gerard
Lassalle Gilbert
Matrougui Mostafa
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HRP20020762A2 publication Critical patent/HRP20020762A2/hr
Publication of HRP20020762B1 publication Critical patent/HRP20020762B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HR20020762A 2000-03-23 2002-09-19 N-(heterocyklyl)benzene or pyridine sulphonamides as antithrombotic agens and anticoagulants HRP20020762B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
PCT/FR2001/000861 WO2001070736A1 (fr) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-ou pyridine sulfonamides comme agents antithrombotiques et anticoagulantes

Publications (2)

Publication Number Publication Date
HRP20020762A2 HRP20020762A2 (en) 2003-12-31
HRP20020762B1 true HRP20020762B1 (en) 2005-02-28

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020762A HRP20020762B1 (en) 2000-03-23 2002-09-19 N-(heterocyklyl)benzene or pyridine sulphonamides as antithrombotic agens and anticoagulants

Country Status (35)

Country Link
US (1) US6680329B2 (sr)
EP (1) EP1268469B1 (sr)
JP (1) JP2003528098A (sr)
KR (1) KR100791693B1 (sr)
CN (1) CN1183128C (sr)
AR (1) AR029900A1 (sr)
AT (1) ATE269325T1 (sr)
AU (2) AU4661701A (sr)
BG (1) BG65863B1 (sr)
BR (1) BR0109385A (sr)
CA (1) CA2401637C (sr)
DE (1) DE60103868T2 (sr)
DK (1) DK1268469T3 (sr)
EA (1) EA004986B1 (sr)
EE (1) EE05084B1 (sr)
ES (1) ES2222358T3 (sr)
FR (1) FR2806722B1 (sr)
HK (1) HK1051537A1 (sr)
HR (1) HRP20020762B1 (sr)
HU (1) HUP0300695A2 (sr)
IL (2) IL151619A0 (sr)
IS (1) IS2304B (sr)
ME (1) MEP17408A (sr)
MX (1) MXPA02009276A (sr)
NO (1) NO324835B1 (sr)
PL (1) PL204660B1 (sr)
PT (1) PT1268469E (sr)
RS (1) RS50370B (sr)
SI (1) SI1268469T1 (sr)
SK (1) SK286687B6 (sr)
TR (1) TR200402343T4 (sr)
TW (1) TWI290141B (sr)
UA (1) UA71667C2 (sr)
WO (1) WO2001070736A1 (sr)
ZA (1) ZA200206996B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
DE60329415D1 (de) 2002-12-06 2009-11-05 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
EP1739077A4 (en) * 2004-04-19 2008-04-16 Daiso Co Ltd PROCESS FOR THE PRODUCTION OF NON-NATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2009126675A1 (en) * 2008-04-09 2009-10-15 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
EP2294051B1 (en) * 2008-05-22 2014-08-13 Boehringer Ingelheim International GmbH Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
EP2528895B1 (en) * 2010-01-28 2016-03-30 The Medicines Company (Leipzig) GmbH Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
NO324835B1 (no) 2007-12-17
EE05084B1 (et) 2008-10-15
DK1268469T3 (da) 2004-10-11
CA2401637A1 (en) 2001-09-27
RS50370B (sr) 2009-11-10
HUP0300695A2 (hu) 2003-07-28
KR100791693B1 (ko) 2008-01-03
AR029900A1 (es) 2003-07-23
BG65863B1 (bg) 2010-03-31
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
FR2806722A1 (fr) 2001-09-28
CA2401637C (en) 2009-11-10
EA200200838A1 (ru) 2003-04-24
PL204660B1 (pl) 2010-01-29
WO2001070736A1 (fr) 2001-09-27
TR200402343T4 (tr) 2004-12-21
EP1268469B1 (fr) 2004-06-16
NO20024496L (no) 2002-11-22
KR20020081476A (ko) 2002-10-26
UA71667C2 (uk) 2004-12-15
CN1183128C (zh) 2005-01-05
IL151619A0 (en) 2003-04-10
YU67002A (sh) 2005-07-19
IL151619A (en) 2009-05-04
PT1268469E (pt) 2004-10-29
JP2003528098A (ja) 2003-09-24
MEP17408A (en) 2010-06-10
HK1051537A1 (en) 2003-08-08
AU2001246617B2 (en) 2006-03-02
FR2806722B1 (fr) 2002-05-17
BR0109385A (pt) 2003-06-03
ATE269325T1 (de) 2004-07-15
IS6535A (is) 2002-08-30
EP1268469A1 (fr) 2003-01-02
ES2222358T3 (es) 2005-02-01
HRP20020762A2 (en) 2003-12-31
PL364988A1 (en) 2004-12-27
CN1426407A (zh) 2003-06-25
US6680329B2 (en) 2004-01-20
ZA200206996B (en) 2003-09-01
SI1268469T1 (en) 2004-10-31
IS2304B (is) 2007-10-15
TWI290141B (en) 2007-11-21
EA004986B1 (ru) 2004-10-28
AU4661701A (en) 2001-10-03
MXPA02009276A (es) 2003-05-23
EE200200540A (et) 2004-04-15
SK286687B6 (sk) 2009-03-05
BG107130A (bg) 2003-06-30
US20030207920A1 (en) 2003-11-06
NO20024496D0 (no) 2002-09-19
SK13512002A3 (sk) 2003-03-04

Similar Documents

Publication Publication Date Title
IL144781A0 (en) Novel sulfonamide compounds and uses thereof
AP2002002505A0 (en) Novel compostition and use
EP1370249A4 (en) NEW DENDRITIC POLYMERS AND ITS BIOMEDICAL APPLICATIONS
AU2001282449A1 (en) Applications of the biofeedback technique
IL162266A0 (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the useof the same
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
AU3994099A (en) Oleophobic laminated articles, assemblies of use, and methods
AU2748800A (en) Fluorochemical oligomer and use thereof
HK1047060B (zh) 可移動的分段式塊體玩具
AU2002366084A1 (en) Absorbent articles having improved stretchability
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
ZA9810222B (en) Chromium nicotinate compositions and uses thereof
AU2002224942A1 (en) N-acyl aminoacetonitriles having pesticidal properties
HRP20020762B1 (en) N-(heterocyklyl)benzene or pyridine sulphonamides as antithrombotic agens and anticoagulants
AU2001246617A1 (en) N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
NO20015068D0 (no) Nya 8A- og 9A-15-medlemmers laktamer
GB0101879D0 (en) Anticoagulants and their uses
AU2001296780A1 (en) 48120, 23479, and 46689, novel human hydrolases and uses thereof
DE50115118D1 (de) Mikromechanisches bauelement und abgleichverfahren
DE60005282D1 (de) Golfschlägerkopf, golfschläger und golfschlägerset
SE9802701D0 (sv) Flytt- och möblerbara väggar
AU2002341775A1 (en) 56294 and 56629, novel human metalloproteases and uses thereof
DK199900429U1 (da) Aktive produkter med værdifulde egenskaber
AU2001294910A1 (en) 3-thioxo-(1,2,4)-oxadiazinan-5-one and their use as anti-antherosclerotic agents

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS, FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20110314

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20120323